Biomarker-guided implementation of the KDIGO guidelines to reduce the occurrence of acute kidney injury in patients after cardiac surgery (PrevAKI-multicentre): protocol for a multicentre, observational study followed by randomised controlled feasibility trial
Mira Küllmar, Christina Massoth, Marlies Ostermann, Sara Campos, Neus Grau Novellas, Gary Thomson, Michael Haffner, Christian Arndt, Hinnerk Wulf, Marc Irqsusi, Fabrizio Monaco, Ambra Di Prima, Mercedes Garcia Alvarez, Stefano Italiano, Virginia Cegarra SanMartin, Gudrun Kunst, Shrijit Nair, Camilla L'Acqua, Eric A J Hoste, Wim Vandenberghe, Patrick M Honore, John Kellum, Lui Forni, Philippe Grieshaber, Raphael Weiss, Joachim Gerss, Carola Wempe, Melanie Meersch, Alexander Zarbock, Mira Küllmar, Christina Massoth, Marlies Ostermann, Sara Campos, Neus Grau Novellas, Gary Thomson, Michael Haffner, Christian Arndt, Hinnerk Wulf, Marc Irqsusi, Fabrizio Monaco, Ambra Di Prima, Mercedes Garcia Alvarez, Stefano Italiano, Virginia Cegarra SanMartin, Gudrun Kunst, Shrijit Nair, Camilla L'Acqua, Eric A J Hoste, Wim Vandenberghe, Patrick M Honore, John Kellum, Lui Forni, Philippe Grieshaber, Raphael Weiss, Joachim Gerss, Carola Wempe, Melanie Meersch, Alexander Zarbock
Abstract
Introduction: Acute kidney injury (AKI) is a frequent complication after cardiac surgery with adverse short-term and long-term outcomes. Although prevention of AKI (PrevAKI) is strongly recommended, the optimal strategy is uncertain. The Kidney Disease: Improving Global Outcomes (KDIGO) guideline recommended a bundle of supportive measures in high-risk patients. In a single-centre trial, we recently demonstrated that the strict implementation of the KDIGO bundle significantly reduced the occurrence of AKI after cardiac surgery. In this feasibility study, we aim to evaluate whether the study protocol can be implemented in a multicentre setting in preparation for a large multicentre trial.
Methods and analysis: We plan to conduct a prospective, observational survey followed by a randomised controlled, multicentre, multinational clinical trial including 280 patients undergoing cardiac surgery with cardiopulmonary bypass. The purpose of the observational survey is to explore the adherence to the KDIGO recommendations in routine clinical practice. The second phase is a randomised controlled trial. The objective is to investigate whether the trial protocol is implementable in a large multicentre, multinational setting. The primary endpoint of the interventional part is the compliance rate with the protocol. Secondary endpoints include the occurrence of any AKI and moderate/severe AKI as defined by the KDIGO criteria within 72 hours after surgery, renal recovery at day 90, use of renal replacement therapy (RRT) and mortality at days 30, 60 and 90, the combined endpoint major adverse kidney events consisting of persistent renal dysfunction, RRT and mortality at day 90 and safety outcomes.
Ethics and dissemination: The PrevAKI multicentre study has been approved by the leading Research Ethics Committee of the University of Münster and the respective Research Ethics Committee at each participating site. The results will be used to design a large, definitive trial.
Trial registration number: NCT03244514.
Keywords: acute renal failure; adult intensive & critical care; cardiac surgery.
Conflict of interest statement
Competing interests: MM, JK and AZ have received lecture fees from Astute Medical, Fresenius and Baxter, unrelated to the current study. JK and AZ have received grant support from Astute Medical, unrelated to the current study. MO has received lecture fees from Biomerieux, Fresenius Medical and Baxter. CA has received lecture fees from Baxter. LF has received research funding from Baxter and Ortho Clinical Diagnostics, consultancy fees from Medibeacon/La Jolla Pharmaceuticals and honoraria from Biomerieux/Astute.
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Figures
References
- Nadim MK, Forni LG, Bihorac A, et al. . Cardiac and vascular Surgery-Associated acute kidney injury: the 20th international consensus conference of the ADQI (acute disease quality initiative) group. J Am Heart Assoc 2018;7 10.1161/JAHA.118.008834. [Epub ahead of print: 01 Jun 2018].
- Chertow GM, Lazarus JM, Christiansen CL, et al. . Preoperative renal risk stratification. Circulation 1997;95:878–84. 10.1161/01.CIR.95.4.878
- Hobson CE, Yavas S, Segal MS, et al. . Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation 2009;119:2444–53. 10.1161/CIRCULATIONAHA.108.800011
- Koyner JL, Bennett MR, Worcester EM, et al. . Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery. Kidney Int 2008;74:1059–69. 10.1038/ki.2008.341
- Rosner MH, Okusa MD. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol 2006;1:19–32. 10.2215/CJN.00240605
- Wijeysundera DN, Karkouti K, Dupuis J-Y, et al. . Derivation and validation of a simplified predictive index for renal replacement therapy after cardiac surgery. JAMA 2007;297:1801–9. 10.1001/jama.297.16.1801
- Ostermann ME, Taube D, Morgan CJ, et al. . Acute renal failure following cardiopulmonary bypass: a changing picture. Intensive Care Med 2000;26:565–71. 10.1007/s001340051205
- Kellum JA, Bellomo R, Ronco C. Kidney attack. JAMA 2012;307:2265–6. 10.1001/jama.2012.4315
- Basile DP, Bonventre JV, Mehta R, et al. . Progression after AKI: understanding maladaptive repair processes to predict and identify therapeutic treatments. J Am Soc Nephrol 2016;27:687–97. 10.1681/ASN.2015030309
- Kellum JA, Angus DC. Patients are dying of acute renal failure. Crit Care Med 2002;30:2156–7. 10.1097/00003246-200209000-00041
- Kellum J ALN, Aspelin P, Barsoum RS, et al. . KDIGO clinical practice guideline for Acte kidney injury 2012. Kidney Int Suppl 2012;2:1–138.
- Leone M, Ragonnet B, Alonso S, et al. . Variable compliance with clinical practice guidelines identified in a 1-day audit at 66 French adult intensive care units. Crit Care Med 2012;40:3189–95. 10.1097/CCM.0b013e31826571f2
- Parikh CR, Coca SG, Thiessen-Philbrook H, et al. . Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery. J Am Soc Nephrol 2011;22:1748–57. 10.1681/ASN.2010121302
- Kashani K, Al-Khafaji A, Ardiles T, et al. . Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 2013;17:R25 10.1186/cc12503
- Meersch M, Schmidt C, Van Aken H, et al. . Urinary TIMP-2 and IGFBP7 as early biomarkers of acute kidney injury and renal recovery following cardiac surgery. PLoS One 2014;9:e93460 10.1371/journal.pone.0093460
- Engelman DT, Ben Ali W, Williams JB, et al. . Guidelines for perioperative care in cardiac surgery: enhanced recovery after surgery Society recommendations. JAMA Surg 2019. 10.1001/jamasurg.2019.1153. [Epub ahead of print: 04 May 2019].
- Meersch M, Schmidt C, Hoffmeier A, et al. . Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial. Intensive Care Med 2017;43:1551–61. 10.1007/s00134-016-4670-3
- Göcze I, Jauch D, Götz M, et al. . Biomarker-Guided intervention to prevent acute kidney injury after major surgery: the prospective randomized BigpAK study. Ann Surg 2018;267:1013–20. 10.1097/SLA.0000000000002485
Source: PubMed